Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

To assess the safety and tolerance of 5 mL to 20 mL PEG 400 in multiple rising doses

Phase 1

Boehringer Ingelheim